Skip to main content
Signal8
Vasisht Niraj profile photo

Niraj Vasisht

CIK: 0001662930

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Inhibitor Therapeutics, Inc. logo
INTI

Inhibitor Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Inhibitor Therapeutics, Inc. logo
    INTI

    Inhibitor Therapeutics, Inc.

    May 5, 2026
    Award(A)
    Direct
    50K shares-
  • Inhibitor Therapeutics, Inc. logo
    INTI

    Inhibitor Therapeutics, Inc.

    Apr 1, 2025
    Award(A)
    Direct
    50K shares-

1-2 of 2

About Vasisht Niraj

Vasisht Niraj (SEC CIK 0001662930) files insider reports with the SEC as Director of Inhibitor Therapeutics, Inc. (INTI).

Signal8 holds 2 ownership filings by Vasisht Niraj, all Form 4s, filed between Apr 10, 2025 and Jun 1, 2026. Those filings report 2 transactions, from Apr 1, 2025 to May 5, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Vasisht Niraj's filings is in TAMPA, FL.

Recent filings by Vasisht Niraj

  • May 5, 2026: Grant or award of INTI shares (Form 4, code A).
  • Apr 1, 2025: Grant or award of INTI shares (Form 4, code A).

Other insiders filing for Inhibitor Therapeutics, Inc. (INTI)

How to read Form 4 transaction codes